etidronate has been researched along with cholecalciferol in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (38.46) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Mawer, EB; Reeve, A; Taylor, CM | 1 |
| Broulík, PD; Pacovský, V; Ston, J; Wilczek, H | 1 |
| Pacovský, V; Ston, J; Wilczek, H | 1 |
| Harley, JP; Newsome, AL | 1 |
| Wada, F | 1 |
| Baxter, LA; Bonjour, JP; Deluca, HF; Fleisch, HA | 1 |
| Jacobellis, U; Ruotolo, G; Salerno, G | 1 |
| Carr, EA; Carroll, M; Montes, M | 1 |
| Bonjour, JP; Eisman, JA; Fleisch, H; Taylor, CM; Trechsel, U | 1 |
| Asteggiano, C; Cañas, F; Moreno, J; Pereira, R; Tolosa, N | 1 |
| Hayashi, Y | 1 |
| Becker, D; Hahn, EG; Hänsler, J; Harsch, IA; Strobel, D | 1 |
| Kobayashi, S; Shiraki, M; Takaoka, K | 3 |
| Fleming, A; Goldsmith, P; Sato, M | 1 |
| Sato, S | 1 |
| Cobaleda, B; Gómez-Juaristi, M; González, EM; Guadalix, S; Hawkins, F; Lora, D; Martínez-Díaz-Guerra, G; Vargas, C | 1 |
| Chin, SO; Chung, HY; Chung, YS; Kang, MI; Koh, JM; Moon, SH; Park, HM; Yoon, BK; Yoon, HK | 1 |
| Audran, M; Chappard, D; Hoppé, E; Laffitte, A; Masson, C | 1 |
| Chang, JS; Chung, HY; Chung, YS; Kang, MI; Koo, J; Kwon, SK; Moon, SH; Park, HM; Park, JY; Shin, CS; Yoon, BK; Yoon, HK | 1 |
| Biamonte, F; Biondi, P; Cipriani, C; Del Fiacco, R; Diacinti, D; Falciano, M; Iaiani, G; Isidori, AM; Lenzi, A; Minisola, S; Pepe, J; Piemonte, S; Raimo, O; Salotti, A; Sbardella, E | 1 |
| Babinets', LS; Borovyk, IO; Semenova, IV | 1 |
| Ashizawa, N; Ishida, K; Iwanaga, T; Kobashi, S; Kurita, N; Matsumoto, K; Shigematsu, T | 1 |
| Hatano, M; Hirota, Y; Hoshino, J; Isawa, K; Kitajima, I; Nakamura, M; Sawa, N; Ubara, Y; Yamamoto, S | 1 |
5 review(s) available for etidronate and cholecalciferol
| Article | Year |
|---|---|
[Advancement of treatment for osteoporosis].
Topics: Alendronate; Bone Density; Cholecalciferol; Clinical Trials as Topic; Estrogen Replacement Therapy; Etidronic Acid; Fractures, Bone; Humans; Hydroxycholecalciferols; Osteoporosis; Raloxifene Hydrochloride; Vitamin K 2 | 2002 |
[Treatment of osteoporosis combined with a bisphosphonate and vitamin D3].
Topics: Alendronate; Bone Density; Cholecalciferol; Drug Therapy, Combination; Etidronic Acid; Humans; Multicenter Studies as Topic; Osteoporosis; Prognosis; Randomized Controlled Trials as Topic; Spinal Fractures | 2004 |
[Effects of concurrent therapy for patients with osteoporosis].
Topics: Aged; Bone Density; Cholecalciferol; Clinical Trials as Topic; Diphosphonates; Drug Therapy, Combination; Estrogen Replacement Therapy; Etidronic Acid; Female; Fractures, Bone; Humans; Male; Multicenter Studies as Topic; Osteoporosis; Vitamin K 2 | 2005 |
[Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].
Topics: Alendronate; Bone Density Conservation Agents; Calcitonin; Cholecalciferol; Etidronic Acid; Evidence-Based Medicine; Glucocorticoids; Humans; Osteoporosis; Randomized Controlled Trials as Topic; Risedronic Acid; Vitamin K 2 | 2007 |
[Concurrent treatment of osteoporosis including vitamin K].
Topics: Bone Density; Bone Density Conservation Agents; Cholecalciferol; Diphosphonates; Drug Therapy, Combination; Estrogen Replacement Therapy; Etidronic Acid; Female; Humans; Male; Multicenter Studies as Topic; Osteoporosis; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Spinal Fractures; Vitamin K 2 | 2007 |
3 trial(s) available for etidronate and cholecalciferol
| Article | Year |
|---|---|
Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Cholecalciferol; Etidronic Acid; Female; Humans; Liver Transplantation; Male; Middle Aged; Postmenopause; Prospective Studies; Risedronic Acid; Spinal Fractures | 2011 |
Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis.
Topics: Aged; Alkaline Phosphatase; Asian People; Bone Density; Bone Density Conservation Agents; Cholecalciferol; Collagen Type I; Double-Blind Method; Drug Therapy, Combination; Etidronic Acid; Female; Gastrointestinal Diseases; Humans; Korea; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptides; Prospective Studies; Radioimmunoassay; Risedronic Acid; Treatment Outcome; Vitamin D | 2011 |
Early changes in 25-hydroxyvitamin D levels and bone markers after monthly risedronate with cholecalciferol in Korean patients with osteoporosis.
Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Biomarkers; Bone Density Conservation Agents; Chi-Square Distribution; Cholecalciferol; Collagen Type I; Double-Blind Method; Drug Combinations; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Peptides; Prospective Studies; Republic of Korea; Risedronic Acid; Treatment Outcome; Vitamin D | 2013 |
18 other study(ies) available for etidronate and cholecalciferol
| Article | Year |
|---|---|
The effects of a diphosphonate and dietary calcium on the metabolism of vitamin D3 (cholecalciferol) in the chick.
Topics: Animals; Calcium; Calcium, Dietary; Chickens; Cholecalciferol; Dihydroxycholecalciferols; Etidronic Acid; Intestinal Mucosa; Kidney; Mixed Function Oxygenases; Organophosphorus Compounds; Vitamin D Deficiency | 1975 |
[Interaction of vitamin D3 and diphosphonate in their action on calcium and phosphorus metabolism (author's transl)].
Topics: Animals; Calcium; Cholecalciferol; Drug Interactions; Etidronic Acid; Male; Organophosphorus Compounds; Phosphorus; Rats | 1976 |
Effects of Trisetum flavescens on calcium and phosphorus metabolism. Mechanism of its action studied through its interaction with diphosphonate.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Calcium; Cholecalciferol; Diet; Etidronic Acid; Male; Phosphates; Phosphorus; Plants; Rats | 1978 |
Trichinella spiralis: acceleration and inhibition of cyst calcification in rats.
Topics: Animals; Calcinosis; Cholecalciferol; Etidronic Acid; Larva; Male; Rats; Trichinella; Trichinellosis | 1978 |
[Calcification-promoting action of vitamin D metabolites on the growth plate cartilage of rats with 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP)-induced rickets].
Topics: Animals; Calcification, Physiologic; Calcitriol; Cartilage; Cholecalciferol; Dihydroxycholecalciferols; Diphosphonates; Etidronic Acid; Female; Growth Plate; Hydroxycholecalciferols; Rats; Rats, Inbred Strains; Rickets | 1987 |
Inhibition of vitamin D metabolism by ethane-1-hydroxyl-1, 1-diphosphonate.
Topics: Animals; Bone and Bones; Calcium; Chickens; Cholecalciferol; Duodenum; Etidronic Acid; Hydroxycholecalciferols; Intestinal Absorption; Kidney; Male; Mitochondria; Organ Specificity; Organophosphorus Compounds; Phosphorus; Vitamin D Deficiency | 1974 |
[The use of 1-alpha-cholecalciferol in subjects treated for a prolonged time with diphosphonates for recurrent calcium nephrolithiasis].
Topics: Cholecalciferol; Drug Therapy, Combination; Etidronic Acid; Humans; Hypophosphatasia; Kidney Calculi; Recurrence | 1984 |
Effect of vitamin D3, other drugs altering serum calcium or phosphorus concentrations, and desoxycorticosterone on the distribution of Tc-99m pyrophosphate between target and nontarget tissues.
Topics: Animals; Calcium; Cardiomyopathies; Cholecalciferol; Desoxycorticosterone; Diphosphates; Drug Interactions; Etidronic Acid; Phosphorus; Radionuclide Imaging; Rats; Technetium; Technetium Tc 99m Pyrophosphate; Tissue Distribution | 1981 |
Plasma levels of vitamin D metabolites in diphosphonate-treated rats.
Topics: 25-Hydroxyvitamin D 2; Animals; Calcitriol; Calcium, Dietary; Cholecalciferol; Dose-Response Relationship, Drug; Ergocalciferols; Etidronic Acid; Male; Phosphorus; Rats; Rats, Inbred Strains; Time Factors | 1981 |
Lack of relationship between activity of intestinal alkaline phosphatase and calcium or phosphate absorption.
Topics: Alkaline Phosphatase; Animals; Calcium; Chickens; Cholecalciferol; Etidronic Acid; Intestinal Absorption; Intestines; Phosphates | 1981 |
[Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous Radio-Frequency-Tissue-Ablation (RFTA)].
Topics: Adenoma; Aged; Bone Density; Calcium; Catheter Ablation; Cholecalciferol; Etidronic Acid; Female; Follow-Up Studies; Humans; Osteoporosis, Postmenopausal; Parathyroid Neoplasms; Thyroid Neoplasms; Time Factors; Treatment Outcome; Ultrasonography | 2002 |
High-throughput in vivo screening for bone anabolic compounds with zebrafish.
Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Calcification, Physiologic; Cholecalciferol; Drug Evaluation, Preclinical; Etidronic Acid; Feasibility Studies; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Osteoblasts; Osteoporosis; Parathyroid Hormone; Zebrafish | 2005 |
[Patient compliance program aids therapy success].
Topics: Alendronate; Bone Density Conservation Agents; Calcium; Cholecalciferol; Clinical Trials as Topic; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Patient Compliance; Risedronic Acid; Time Factors | 2009 |
Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
Topics: Aged, 80 and over; Alkaline Phosphatase; Biopsy; Bone Density Conservation Agents; Calcification, Physiologic; Calcium Carbonate; Cholecalciferol; Etidronic Acid; Female; Femoral Fractures; Fibula; Fractures, Spontaneous; Humans; Hyperparathyroidism, Secondary; Iatrogenic Disease; Osteitis Deformans; Osteolysis; Osteomalacia; Parathyroid Hormone; Radionuclide Imaging; Rib Fractures; Tibial Fractures; Ulna; Vitamin D | 2012 |
Effect of risedronate in osteoporotic HIV males, according to gonadal status: a pilot study.
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Cholecalciferol; Drug Therapy, Combination; Etidronic Acid; HIV Infections; Humans; Hypogonadism; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Pilot Projects; Risedronic Acid; Testosterone; Treatment Outcome | 2014 |
[Osteodeficiency in chronic pancreatitis: ways of correction].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcification, Physiologic; Calcium Carbonate; Cholecalciferol; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteoporosis; Pancreatitis, Chronic; Risedronic Acid | 2014 |
Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats.
Topics: Animals; Aorta; Biomarkers; Bone Resorption; Cells, Cultured; Cholecalciferol; Diphosphonates; Etidronic Acid; Humans; Male; Myocytes, Smooth Muscle; Rats, Wistar; Tartrate-Resistant Acid Phosphatase; Vascular Calcification | 2019 |
Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis.
Topics: Bone and Bones; Bone Density Conservation Agents; Calcitriol; Cholecalciferol; Etidronic Acid; Humans; Ilium; Male; Middle Aged; Osteitis Fibrosa Cystica; Osteomalacia; Renal Dialysis; Vitamin D Deficiency | 2021 |